You have 9 free searches left this month | for more free features.

City

Condition

B-cell Lymphoid Malignancies (2)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

Shanghai Escugen Biotechnology Co., Ltd (2)

Collaborator

Escugen (Australia) Biotechnology Pty Ltd (1)

Intervention

esg206 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

esg206

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B-cell Lymphoid Malignancies Trial (ESG206)

Not yet recruiting

B-cell Lymphoid Malignancies

ESG206

(no location specified)

Apr 10, 2023

B-cell Lymphoid Malignancies Trial (ESG206)

Not yet recruiting

B-cell Lymphoid Malignancies

ESG206

(no location specified)

Aug 8, 2022